Breaking News

CPhI Shares Key Findings from Annual Report

Predicts that CMOs will account for four of the five top bio manufacturing capacities in 2025.

Author Image

By: Charlie Sternberg

Associate Editor

The third part of the CPhI Annual Report has been released with key findings for biologics manufacturing, biotechs and CDMOs.   CPhI experts – Dawn Ecker, managing director of bioTRAK Database Services at BDO and Fiona Barry, editor at GlobalData PharmSource – look ahead to 2025 to predict the future demand for biologicals by volume, as well as the total capacity available and, the consequential impact in the short-to-medium term of the proliferation of Covid-19 supply contracts.   These new fin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters